CENPI Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-87169
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N-terminal region of Human CENPI. Peptide sequence: SKNISKHGQNNPVGDYEHADDQAEEDALQMAVGYFEKGPIKASQNKDKTL The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for CENPI Antibody
![Western Blot: CENPI Antibody [NBP2-87169]](https://resources.bio-techne.com/images/products/CENPI-Antibody-Western-Blot-NBP2-87169-img0001.jpg "Western Blot: CENPI Antibody [NBP2-87169]")
Western Blot: CENPI Antibody [NBP2-87169]
Western Blot: CENPI Antibody [NBP2-87169] - Host: Rabbit. Target Name: CENPI. Sample Type: Thyroid Tumor lysates. Antibody Dilution: 1.0ug/mlApplications for CENPI Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CENPI
Alternate Names
CENP-IFSH primary response (LRPR1, rat) homolog 1, centromere protein I, Follicle-stimulating hormone primary response protein, FSH primary response 1, FSH primary response protein 1, FSHPRH1Mis6, ICEN19, Interphase centromere complex protein 19, Leucine-rich primary response protein 1, LRPR1FSH primary response (LRPR1 homolog, rat) 1, Mis6
Gene Symbol
CENPI
Additional CENPI Products
Product Specific Notices for CENPI Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...